SEC Form 4 · accession 0001192482-15-000211
COLLEGIUM PHARMACEUTICAL, INC · COLL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Brannelly
Officer — Executive Vice President & CFO
Period of report
May 14, 2015
Accepted (ET)
May 18, 2015 · 7:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267565
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Purchase)F1 | $14.90 | May 14, 2015 | A | 22,929 | A | — | May 14, 2025 | Common Stock | 22,929 | 22,929 | D |
Explanation of responses
- F1The options vest and become exercisable over a 4-year period commencing on May 14, 2015. Twenty-five percent (25%) of the options vest and become exercisable on May 14, 2016, and the balance of the shares vest in equal monthly installments (rounded up to the nearest whole option) over the remaining three years of the 4-year period.